{ "company_number": "08059569", "name": "Delta Pharmaceutics Limited", "url": "/company/08059569", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2012-05-08", "dissolved_on": null, "sic_codes": [ "74909" ], "registered_address": { "id": 1246656, "url": "/address/1246656", "line1": "1 - 3 MANOR ROAD", "line2": "", "post_town": "CHATHAM", "county": "", "country": "ENGLAND", "postcode": "ME4 6AE" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/08059569", "previous_names": [], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2027-02-28", "last_made_up": "2025-05-31", "category": "TOTAL EXEMPTION FULL", "filings": [ { "url": "/company/08059569/accounts/2025-05-31", "made_up_date": "2025-05-31", "period_start": "2024-06-01", "period_end": "2025-05-31", "entity_name": "Delta Pharmaceutics Limited", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "6519.00", "debtors": "241134.00", "cash_bank_in_hand": "19918.00", "current_assets": "261052.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "96544.00", "total_assets_less_current_liabilities": "103063.00", "net_assets_liabilities": "103063.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "30200.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "-42603.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2026.zip" }, { "url": "/company/08059569/accounts/2024-05-31", "made_up_date": "2024-05-31", "period_start": "2023-06-01", "period_end": "2024-05-31", "entity_name": "Delta Pharmaceutics Limited", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "7940.00", "debtors": "218120.00", "cash_bank_in_hand": "87638.00", "current_assets": "305758.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "139711.00", "total_assets_less_current_liabilities": "147651.00", "net_assets_liabilities": "145666.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "30200.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "15804.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2025.zip" }, { "url": "/company/08059569/accounts/2023-05-31", "made_up_date": "2023-05-31", "period_start": "2022-06-01", "period_end": "2023-05-31", "entity_name": "Delta Pharmaceutics Limited", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "9969.00", "debtors": "46744.00", "cash_bank_in_hand": "195396.00", "current_assets": "242140.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "92405.00", "total_assets_less_current_liabilities": "102374.00", "net_assets_liabilities": "99862.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "200.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "63846.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2024.zip" }, { "url": "/company/08059569/accounts/2022-05-31", "made_up_date": "2022-05-31", "period_start": "2021-06-01", "period_end": "2022-05-31", "entity_name": "Delta Pharmaceutics Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "6499.00", "debtors": "50416.00", "cash_bank_in_hand": "117129.00", "current_assets": "167545.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "29517.00", "total_assets_less_current_liabilities": "36016.00", "net_assets_liabilities": null, "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "200.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "-6900.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2023.zip" }, { "url": "/company/08059569/accounts/2021-05-31", "made_up_date": "2021-05-31", "period_start": "2020-06-01", "period_end": "2021-05-31", "entity_name": "Delta Pharmaceutics Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "2508.00", "debtors": "40083.00", "cash_bank_in_hand": "129752.00", "current_assets": "169835.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "40408.00", "total_assets_less_current_liabilities": "42916.00", "net_assets_liabilities": "42916.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "200.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "-17494.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-April2022.zip" }, { "url": "/company/08059569/accounts/2020-05-31", "made_up_date": "2020-05-31", "period_start": "2019-06-01", "period_end": "2020-05-31", "entity_name": "Delta Pharmaceutics Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "1371.00", "debtors": "61577.00", "cash_bank_in_hand": "138960.00", "current_assets": "200537.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "59299.00", "total_assets_less_current_liabilities": "60670.00", "net_assets_liabilities": "60410.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "200.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "28107.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2020.zip" }, { "url": "/company/08059569/accounts/2019-05-31", "made_up_date": "2019-05-31", "period_start": "2018-06-01", "period_end": "2019-05-31", "entity_name": "Delta Pharmaceutics Limited", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "701.00", "debtors": "20000.00", "cash_bank_in_hand": "137090.00", "current_assets": "157090.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "31735.00", "total_assets_less_current_liabilities": "32436.00", "net_assets_liabilities": "32303.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "200.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "14650.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2020.zip" }, { "url": "/company/08059569/accounts/2018-05-31", "made_up_date": "2018-05-31", "period_start": "2017-06-01", "period_end": "2018-05-31", "entity_name": "Delta Pharmaceutics Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "935.00", "debtors": "23214.00", "cash_bank_in_hand": "108523.00", "current_assets": "131737.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "16718.00", "total_assets_less_current_liabilities": "17653.00", "net_assets_liabilities": null, "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "200.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "-10839.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2019.zip" }, { "url": "/company/08059569/accounts/2017-05-31", "made_up_date": "2017-05-31", "period_start": "2016-06-01", "period_end": "2017-05-31", "entity_name": "Delta Pharmaceutics Limited", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "1246.00", "debtors": "20681.00", "cash_bank_in_hand": "111934.00", "current_assets": "132615.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "27246.00", "total_assets_less_current_liabilities": "28492.00", "net_assets_liabilities": "28492.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "200.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "-5147.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2018.zip" }, { "url": "/company/08059569/accounts/2016-05-31", "made_up_date": "2016-05-31", "period_start": "2016-05-31", "period_end": "2016-05-31", "entity_name": "Delta Pharmaceutics Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "1661.00", "debtors": "23842.00", "cash_bank_in_hand": "105817.00", "current_assets": "129659.00", "creditors_due_within_one_year": "97349.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "32310.00", "total_assets_less_current_liabilities": "33971.00", "net_assets_liabilities": "33639.00", "called_up_share_capital": "200.00", "profit_loss_account_reserve": "33439.00", "shareholder_funds": "33639.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-March2017.zip" }, { "url": "/company/08059569/accounts/2015-05-31", "made_up_date": "2015-05-31", "period_start": "2015-05-31", "period_end": "2015-05-31", "entity_name": "Delta Pharmaceutics Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "2215.00", "debtors": "30288.00", "cash_bank_in_hand": "174244.00", "current_assets": "204532.00", "creditors_due_within_one_year": "76482.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "128050.00", "total_assets_less_current_liabilities": "130265.00", "net_assets_liabilities": "129822.00", "called_up_share_capital": "200.00", "profit_loss_account_reserve": "129622.00", "shareholder_funds": "129822.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2016.zip" }, { "url": "/company/08059569/accounts/2014-05-31", "made_up_date": "2014-05-31", "period_start": "2014-05-31", "period_end": "2014-05-31", "entity_name": "Delta Pharmaceutics Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": "9462.00", "current_assets": "9462.00", "creditors_due_within_one_year": "11898.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-2436.00", "total_assets_less_current_liabilities": null, "net_assets_liabilities": null, "called_up_share_capital": "100.00", "profit_loss_account_reserve": "-2536.00", "shareholder_funds": "-2436.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2015.zip" }, { "url": "/company/08059569/accounts/2013-05-31", "made_up_date": "2013-05-31", "period_start": "2013-05-31", "period_end": "2013-05-31", "entity_name": "Delta Pharmaceutics Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": "193.00", "cash_bank_in_hand": "2726.00", "current_assets": "2919.00", "creditors_due_within_one_year": "8370.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-5451.00", "total_assets_less_current_liabilities": null, "net_assets_liabilities": null, "called_up_share_capital": "100.00", "profit_loss_account_reserve": "-5551.00", "shareholder_funds": "-5451.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2014.zip" } ], "pdf_only_filings": [], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/08059569/filing-history" }, "confirmation_statement": { "next_due": "2027-05-22", "last_made_up": "2026-05-08" }, "officers": [], "psc": [ { "name": "Mrs Eleni Angeliki Theodosi", "kind": "individual-person-with-significant-control", "person_url": "/person/1413009", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent", "voting-rights-25-to-50-percent" ], "notified_on": "2024-03-01", "ceased_on": null, "nationality": "Greek", "country_of_residence": "United Kingdom", "source": "snapshot" }, { "name": "Dr Dionysios Dennis Douroumis", "kind": "individual-person-with-significant-control", "person_url": "/person/1323179", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-50-to-75-percent", "voting-rights-50-to-75-percent" ], "notified_on": "2016-04-06", "ceased_on": null, "nationality": "Greek", "country_of_residence": "England", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-08-01", "retrieved_at": "2026-08-02T05:12:20.351914+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }